GoodRX called out for bad behavior
GoodRX, a discount drug app used by millions to find lower prices on prescription drugs, has been accused by the US Federal Trade Commission (FTC) of sharing users’ personal data about medications and illnesses with Facebook, Google and other companies. Done without authorization, this is in violation of federal rules requiring health apps to notify consumers of wrongful disclosure of information. The company, though denying the charges, has agreed to settle. Additionally important, according to the New York Times, is that “this is the first time the FTC has brought an enforcement action using its Health Breach Notification Rule.”